Visitor Ratings
Google PR
Visitor Ratings
Google PR
Visitor Ratings
Google PR
Visitor Ratings
Google PR
Visitor Ratings
Google PR ThromboGenics Begins Phase III Program With Microplasmin for the ... FOXBusiness - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on innovative treatments for eye disease, vascular disease and cancer, ... |
![]() dBTechno | Genomic Study Yields Gene That Helps Predict Leukemia Relapse GenomeWeb News, NY - In an effort to identify molecular risk factors for predicting which patients will respond best to existing treatments, the researchers did genetic ... Discovery aids cancer treatment New finding could be major help to young leukemia patients Gene Predicts Childhood Leukemia Relapse |
St. Clare's offers new treatment to cancer patients Dailyrecord.com, NJ - By Michael Daigle • Daily Record • January 8, 2009 DOVER -- St. Clare's Health Systems unveiled Wednesday the latest addition to its cancer-treatment ... Siteman Cancer Center Adds Second TomoTherapy® Hi·Art® Treatment ... |